Multidisciplinary Treatment of Head and Neck Cancer

ABSTRACT

Head and neck cancer remains a significant cause of morbidity worldwide. Multimodality treatment is often the only way to achieve improved function, quality of life, and survival, calling for a multidisciplinary team approach, particularly in view of the rapid advances being made in various fields. The roles of the head and neck surgeon and reconstructive surgeon are discussed, together with the input afforded by specialists in areas such as diagnostic imaging, radiation therapy, medical oncology, and gene therapy. Telemedicine is of importance in centers where multidisciplinary expertise is not available.

KEYWORDS

Multidisciplinary team - tele-oncology - tumor boards

REFERENCES

• 1 Petty J K, Vetto J T. Beyond doughnuts: tumor board recommendations influence patient care.  J Cancer Educ. 2002;  17 97-100
• 2 Moore C. Changing concepts in head and neck surgical oncology: The Hayes Martin Lecture.  Am J Surg. 1980;  140 480-486
• 3 Kehrl W, Tolkemitt J, Düsterhus P. [Comparison between transoral microsurgery by CO2 laser and conventional surgical therapy for T2 glottic carcinoma].  Laryngorhinootologie. 2003;  82 189-194
• 4 Taylor G I. The angiosomes of the body and their supply to perforator flaps.  Clin Plast Surg. 2003;  30 331-342, v
• 5 Koshima I. A new classification of free combined or connected tissue transfers: introduction to the concept of bridge, siamese, chimeric, mosaic, and chain-circle flaps.  Acta Med Okayama. 2001;  55 329-332
• 6 van de Wiele C, Lahorte C, Vermeersch H et al.. Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography.  J Clin Oncol. 2003;  21 3483-3487
• 7 Stoeckli S J, Pfaltz M, Ross G L et al.. The second international conference on sentinel node biopsy in mucosal head and neck cancer.  Ann Surg Oncol. 2005;  12 919-924
• 8 Suit H. [Coming technical advances in radiation oncology].  Z Med Phys. 2005;  15 215-227
• 9 Pai V R, Mazumdar A T, Deshmukh C D et al.. Two- vs three-drug combination chemotherapy in advanced or recurrent head and neck cancer: a single institution experience of 361 patients.  Med Oncol. 2004;  21 305-308
• 10 Endo S, Suzuki S, Tsuji K et al.. [Concurrent chemoradiotherapy for advanced hypopharyngeal cancer.  Nippon Jibiinkoka Gakkai Kaiho. 2005;  108 980-985
• 11 Devlin J, Sherman E. Combined modality treatment of squamous cell cancer of the head and neck.  Clin Adv Hematol Oncol. 2005;  3 373-382
• 12 Lamont J P, Kuhn J A, Nemunaitis J J, McCarty T M. Gene therapy for head and neck cancers.  Oncology (Williston Park). 2001;  15 303-308 discussion 311-314
• 13 Stalfors J, Edström S, Björk-Eriksson T, Mercke C, Nyman J, Westin T. Accuracy of tele-oncology compared with face-to-face consultation in head and neck cancer case conferences.  J Telemed Telecare. 2001;  7 338-343